ALEXANDRA CONROY: Open Payments
NPI 1124726906 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 21 payments from 8 companies in 2025. Trend: 2023 $803 · 2024 $1,678 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $187 |
| Amgen Inc. | 4 | $96 |
| PFIZER INC. | 3 | $55 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| ABIOMED | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
Products named: WATCHMAN FLX, REPATHA, VERQUVO, LEQVIO, VYNDAQEL, WAINUA, ELIQUIS, LOKELMA.
Industry payments across VA — which companies pay providers there.
